Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial
Giacomo Gianfaldoni, Renato Bassan(Pittini Group (Italy)), Ilaria Cutini(Azienda Ospedaliero-Universitaria Careggi), Dario Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Chiara Pavoni(Ospedale Papa Giovanni XXIII), Francesco Mannelli(University of Florence), Sara Bencini(University of Florence), Alberto Bosi(Azienda Ospedaliero-Universitaria Careggi), Arianna Masciulli(Ospedale Papa Giovanni XXIII), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Tamara Intermesoli(University of Bergamo), Damiano Giupponi(Ospedale Papa Giovanni XXIII), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Maria Ida Bonetti(University of Florence), Giorgio Farina(Ospedale dell' Angelo), Anna Maria Scattolin(Ospedale dell' Angelo)
Cited by 15
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627